Skip to main content

Archived Comments for: A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat

Back to article

  1. Author addendum

    Matthew Reilly, InTouch Medical Ltd

    17 September 2015

    In addition to the contributors already listed in the published acknowledgments section of this manuscript, the authors would also like to thank Carine François and her collaborators at Biocodex, France.

    Competing interests

    None declared